EFFICACY OF LOW-DOSE INVOLVED-FIELD RADIOTHERAPY FOLLOWING 3-4 CYCLES OF CHEMOTHERAPY FOR PATIENTS WITH STAGE I-II AGGRESSIVE NON-HODGKIN'S LYMPHOMA

被引：0
|
作者：
Gauthier, I. [1 ]
Despres, P. [1 ]
Roy, I. [1 ]
机构：
[1] Univ Montreal, Montreal, PQ, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2009年 / 92卷
关键词：
D O I：
10.1016/S0167-8140(12)72430-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
43
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [21] Involved-Field Radiotherapy (IFRT) after induction chemotherapy with 4-6 cycles of ABVD in early stage (I/IIA) Hodgkin Lymphoma: long term results of a single institution
    Sotiropoulou, A.
    Fragandrea, I.
    Tsalafoutas, I.
    Bakiri, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 568 - 568
  • [22] A phase II trial of adjuvant low-dose total body irradiation in Non-Hodgkin's lymphoma patients following standard CHOP
    Safwat, A
    Bayoumi, Y
    Akkoush, H
    Mahmoud, H
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S206 - S206
  • [23] A phase II trial of adjuvant low-dose total body irradiation in non-Hodgkin's lymphoma patients following standard CHOP
    Safwat, A
    Bayoumi, Y
    Akkoush, H
    Mahmoud, HK
    ACTA ONCOLOGICA, 2004, 43 (05) : 480 - 485
  • [24] Treatment for non-Hodgkin's lymphoma (stage I, II) of the elderly: Usefulness of local and regional irradiation and reduced dose chemotherapy
    Oguchi, M
    Izuno, I
    Takei, K
    Shikama, N
    Sasaki, S
    Gomi, K
    Sone, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (01): : 87 - 92
  • [25] The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma
    Kamath, SS
    Marcus, RB
    Lynch, JW
    Mendenhall, NP
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (03): : 563 - 568
  • [26] MACOP-B regimen followed by involved-field radiation therapy in early-stage aggressive non-Hodgkin's lymphoma patients: 14-year update results
    Zinzani, PL
    Stefoni, V
    Tani, M
    Barbieri, E
    Albertini, P
    Vigna, E
    Gherlinzoni, F
    Alinari, L
    Galuppi, A
    Pileri, S
    Babini, L
    Tura, S
    LEUKEMIA & LYMPHOMA, 2001, 42 (05) : 989 - 995
  • [27] Impact of low-dose involved-field radiation therapy on pediatric patients with lymphocyte-predominant Hodgkin lymphoma treated with chemotherapy: A report from the Children's Oncology Group
    Appel, Burton E.
    Chen, Lu
    Buxton, Allen
    Wolden, Suzanne L.
    Hodgson, David C.
    Nachman, James B.
    PEDIATRIC BLOOD & CANCER, 2012, 59 (07) : 1284 - 1289
  • [28] Cost benefit and clinical efficacy of low-dose granulocyte colony-stimulating factor after standard chemotherapy in patients with non-Hodgkin's lymphoma
    Hashino, S.
    Morioka, M.
    Irie, T.
    Shiroshita, N.
    Kawamura, T.
    Suzuki, S.
    Iwasaki, H.
    Umehara, S.
    Kakinoki, Y.
    Kurosawa, M.
    Kahata, K.
    Izumiyama, K.
    Kobayashi, H.
    Onozawa, M.
    Takahata, M.
    Fujisawa, F.
    Kondo, T.
    Asaka, M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 (04) : 292 - 299
  • [29] Phase II study of palliative low-dose local radiotherapy in disseminated indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia
    Jóhannsson, J
    Specht, L
    Mejer, J
    Jensen, BA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (05): : 1466 - 1470
  • [30] Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma:: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group
    Engert, A
    Schiller, P
    Josting, A
    Herrmann, R
    Koch, P
    Sieber, M
    Boissevain, F
    de Wit, M
    Mezger, J
    Dühmke, E
    Willich, N
    Müller, RP
    Schmidt, BF
    Renner, H
    Müller-Hermelink, HK
    Pfistner, B
    Wolf, J
    Hasenclever, D
    Löffler, M
    Diehl, V
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) : 3601 - 3608
12345